6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02879136 (ClinicalTrials.gov)	December 2016	23/6/2016	TAME-PD - Physical Therapy, Atomoxetineand, Methylphenidate, to Enhance Gait and Balance in Parkinso ...	TAME-PD - Physical Therapy, Atomoxetineand, Methylphenidate, to Enhance Gait and Balance in Parkinso ...	Parkinson's Disease, Idiopathic	Drug: Methylphenidate;Other: Physical Therapy;Drug: Atomoxetine	Hubert Fernandez	NULL	Recruiting	18 Years	90 Years	All	42	Early Phase 1	United States
2	NCT03651856 (ClinicalTrials.gov)	January 2013	2/7/2018	Atomoxetine for Freezing of Gait in Parkinson's Disease	A Pilot Study of Atomoxetine for Freezing of Gait in Parkinson's Disease	Parkinson's Disease;Freezing of Gait	Drug: ATM FOG in PD	Medical University of South Carolina	NULL	Completed	18 Years	80 Years	All	10	Phase 3	United States
3	NCT01738191 (ClinicalTrials.gov)	November 2012	28/11/2012	Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)	Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)	Parkinson's Disease;Cognitive Impairment	Drug: Atomoxetine;Drug: Placebo	Medical University of South Carolina	Michael J. Fox Foundation for Parkinson's Research	Completed	35 Years	75 Years	All	30	Phase 2	United States
4	NCT00286949 (ClinicalTrials.gov)	January 6, 2005	3/2/2006	Treatment of Executive Dysfunction in Parkinson's Disease	Atomoxetinefor the Treatment of Executive Dysfunction in Patients With Parkinson's Disease: A Pilot ...	Parkinson's Disease	Drug: Atomoxetine	Johns Hopkins University	Eli Lilly and Company	Completed	21 Years	65 Years	All	12	N/A	United States
5	NCT00304161 (ClinicalTrials.gov)	July 2004	15/3/2006	Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease	Depression Diagnosis and Treatment in Parkinson Disease	Depressive Disorder;Parkinson Disease	Drug: Atomoxetine;Drug: Placebo	University of Pennsylvania	National Institute of Mental Health (NIMH)	Completed	30 Years	79 Years	All	55	Phase 4	United States

First Previous1Next Last